Текст книги "Шизофрения: книга в помощь врачам, пациентам и членам их семей."

Рекомендуем прочитать

****Anonymous. “Video and Poor Insight in Persons with Schizophrenia.” Schizophrenia Bulletin 42 (2016): 262–63.

Amador, X. I Am Not Sick, I Don’t Need Help! Peconic, N.Y.: Vida Press, 2000.

Bogart, T., and P. Solomon. “Procedures to Share Treatment Information among Mental Health Providers, Consumers, and Families.” Psychiatric Services 5 0 (1999): 13 21–25.

Caldwell, C.B., and I.I. Gottesman. “Schizophrenics Kill Themselves Too: A Review of Risk Factors for Suicide.” Schizophrenia Bulletin 16 (1990): 571–89.

Cather, C., R.S. Barr, and A.E. Evins. “Smoking and Schizophrenia: Prevalence, Mechanisms and Implications for Treatment.” Clinical Schizophrenia & Related Psychoses 2 (2008): 70–78.

Choe, J.Y., L.A. Teplin, К.M. Abram. “Perpetration of Violence, Violent Victimization, and Severe Mental Illness: Balancing Public Health Concerns.” Psychiatric Services 59 (2008): 153–64.

Citrome, L., and J. Volavka. “Management of Violence in Schizophrenia.” Psychiatric Annals 30 (2000): 41–52.

***Coverdale, J.H., L.B. McCullough, and F.A. Chervenak. “Assisted and Surrogate Decision Making for Pregnant Patients Who Have Schizophrenia.” Schizophrenia Bulletin 30 (2004): 659–64.

De Boer, M.K., S. Castlelein, D. Wiersma. “The Facts about Sexual (Dys)function in Schizophrenia: An Overview of Clinically Relevant Findings.” Schizophrenia Bulletin 41 (2015): 674–86.

Diamond, R. “Drugs and the Quality of Life: The Patient’s Point of View.” Journal of Clinical Psychiatry 46 (1985): 29–35.

Dickerson, F., J. Schroeder, E. Katsafanas, et al. “Cigarette Smoking by Patients With Serious Mental Illness, 1999–2016: An Increasing Disparity.” Psychiatric Services 69 (2018): 147–53.

Drake, R.E., C. Mercer-McFadden, К.T. Mueser, et al. “Review of Integrated Mental Health and Substance Abuse Treatment for Patients with Dual Disorders.” Schizophrenia Bulletin 24 (1998): 589–608.

*Drake, R.E., A.E. Luciano, K.T. Muesser, et al. “Longitudinal Course of Clients With Co-Occurring Schizophrenia-Spectrum and Substance Use Disorders in Urban Mental Health Centers: a 7-Year Prospective Study.” Schizophrenia Bulletin 42 (2016): 202–211.

Empfield, M.D. “Pregnancy and Schizophrenia.” Psychiatric Annals 30 (2000): 61–66.

Hyde, A.P. “Coping with the Threatening, Intimidating, Violent Behaviors of People with Psychiatric Disabilities Living at Home: Guidelines for Family Caregivers.” Psychiatric Rehabilitation Journal 21(1997): 144–49.

Jamison, K.R. Night Falls Fast: Understanding Suicide. New York: Alfred A. Knopf, 1999.

Lamb, H.R., and L.E. Weinberger. “Mental Health Courts as a Way to Provide Treatment to Violent Persons with Severe Mental Illness.” Journal of the American Medical Association 300 (2008): 722–24.

Malik, P., Gt. Kemmler, M. Hummer, et al. “Sexual Dysfunction in First-Episode Schizophrenia Patients: Results from European First Episode Schizophrenia Trial.” Journal of Clinical Psychopharmacology 31 (2011): 274–80.

Marshall, T., and P. Solomon. “Professionals’ Responsibilities in Releasing Information to Families of Adults with Mental Illness.” Psychiatric Services 54 (2003): 1622–28.

**McCullough, L.B., J. Coverdale, T. Bayer, et al. “Ethically Justified Guidelines for Family Planning Interventions to Prevent Pregnancy in Female Patients with Chronic Mental Illness.” American Journal of Obstetrics and Gynecology 167 (1992): 19–25.

Minkoff, K., and R.E. Drake, eds. Dual Diagnosis of Major Meatal Illness and Substance Abuse. San Francisco: Jossey-Bass, 1991.

Monahan, J., A.D. Redlich, J. Swanson, et al. “Use of Leverage to Improve Adherence to Psychiatric Treatment in the Community.” Psychiatric Services 56 (2005): 37–44.

Petrakis, I.L., C. Nich, and E. Ralevski. “Psychotic Spectrum Disorders and Alcohol Abuse: A Review of Pharmacotherapeutic Strategies and a Report on the Effectiveness of Naltrexone and Disulfiram.” Schizophrenia Bulletin 32 (2006): 644–54.

Roy, L., A.G. Crocker, T.L. Nicholls, et al. “Criminal Behavior and Victimization Among Homeless Individuals With Severe Mental Illness: A Systematic Review.” Psychiatric Services 65 (2014): 739–50.

Swanson, J.W., M.S. Swartz, R. Borum, et al. “Involuntary Out-Patient Commitment and Reduction of Violent Behaviour in Persons with Severe Mental Illness.” British Journal of Psychiatry 176 (2000): 224–31.

Torrey, E.F. Out of the Shadows: Confronting America’s Mental Illness Crisis. New York: John Wiley and Sons, 1997.

Torrey, E.F., and M. Zdanowicz. “Outpatient Commitment: What, Why, and for Whom?” Psychiatric Services 53 (2001): 337–41.

Torrey, E.F., J. Stieber, J. Ezekiel, et al. Criminalizing the Seriously Mentally Ill: The Abuse of Jails as Mental Hospitals. Washington, D.C.: Health Research Group and National Alliance for the Mentally Ill, 1992.

Torrey, E.F., M.T. Zdanowicz, A.D. Kennard, et al. “The Treatment of Persons with Mental Illness in Prisons and Jails: A State Survey.” Treatment Advocacy Center (2014). http://www.treatmentadvocacycenter.org/storage/documents/treatment-behind-bars/treatment-behind-bars.pdf

Velligan, D.I., M. Sajatovic, A. Hatch, A. et al. “Why do Psychiatric Patients Stop Antipsychotic Medication? A Systematic Review of Reasons for Nonadherence to Medication in Patients with Serious Mental Illness.” Patient Preference and Adherence 11 (2017): 449–68.

Цитируемые источники

Anonymous, “Admissions to Hospitals for the Insane,” American Journal of Insanity 25 (1868): 74.

F. Dickerson, J. Schroeder, E. Katsafanas, et al., “Cigarette Smoking by Patients with Serious Mental Illness, 1999–2016: An Increasing Disparity,” Psychiatric Services 69 (2018): 147–53.

C. Cather, G.N. Pachas, K.M. Cieslak, et al., “Achieving Smoking Cessation in Individuals with Schizophrenia,” CNS Drugs 31 (2017): 471–81.

F. Dickerson, M.B. Adamos, E. Katsafanas et al., “The Association Among Smoking, HSV-1 Exposure, and Cognitive Functioning in Schizophrenia, Bipolar Disorder, and Non– Psychiatric Controls,” Schizophrenia Research 176 (2016): 566–71.

J. I. Benson and J.J. David, “Coffee Eating in Chronic Schizophrenic Patients,” American Journal of Psychiatry 143 (1986): 940–41.

P. B. Lucas, D. Pickar, J. Kelsoe, et al., “Effects of the Acute Administration of Caffeine in Patients with Schizophrenia,” Biological Psychiatry 28 (1990): 35–40.

S. R. Hirsch, “Precipitation of Antipsychotic Drugs in Interaction with Coffee or Tea,” letter, Lancet 2 (1979): 1130–31.

M. O. Zaslove, R.L. Russell, and E. Ross, “Effect of Caffeine Intake on Psychotic In-Patients,” British Journal of Psychiatry 159 (1991): 565–67.

F. Kulhanek, O.K. Linde, and G. Meisenberg, “Precipitation of Antipsychotic Drugs in Interaction with Coffee or Tea,” letter, Lancet 2 (1979): 1130.

J. A. Cabarillo, A.G. Herraiz, S.I. Ramos, et al., “Effects of Caffeine Withdrawal from the Diet on the Metabolism of Clozapine in Schizophrenic Patients,” Journal of Clinical Psychopharmacology 18 (1998): 311–16.

D. A. Regier, M.E. Farmer, D.S. Rae, et al., “Comorbidity of Mental Disorders with Alcohol and Other Drug Abuse,” Journal of American Medical Association 264 (1990): 2511–18.

Substance Abuse and Mental Health Services Administration, Results from the 2002 National Survey on Drug Use and Health: Detailed Tables (U.S. Department of Health and Human Services, 2003).

C. A. Pristach and C.M. Smith, “Self-Reported Effects of Alcohol Use on Symptoms of Schizophrenia,” Psychiatric Services 47 (1996): 421–23.

R. E. Drake and M.A. Wallach, “Substance Abuse among the Chronically Ill,” Hospital and Community Psychiatry 40 (1989): 1041–46.

M. S. Swartz, J.W. Swanson, and M.J. Hannon, “Detection of Illicit Substance Use among Persons with Schizophrenia by Radioimmunoassay of Hair,” Psychiatric Services 54 (2003): 891–95.

S. J. Kingsbury and C. Salzman, “Disulfiram in the Treatment of Alcoholic Patients with Schizophrenia,” Hospital and Community Psychiatry 41 (1990): 133–34.

R. Warner, D. Taylor, J. Wright, et al., “Substance Use among the Mentally Ill: Prevalence, Reasons for Use, and Effects on Illness,” American Journal of Orthopsychiatry 64 (1994): 30–39.

V. Peralta and M.J. Cuesta, “Influence of Cannabis Abuse on Schizophrenic Psychopathology,” Acta Psychiatrica Scandinavica 85 (1992): 127–30.

J. Coverdale, J. Aruffo, and H. Grunebaum, “Developing Family Planning Services for Female Chronic Mentally Ill Outpatients,” Hospital and Community Psychiatry 43 (1992): 475–77.

J. A. Kelly, D.A. Murphy, G.R. Bahr, et al., “AIDS/HIV Risk Behavior among the Chronically Mentally Ill,” American Journal of Psychiatry 149 (1992): 886–89.

K. McKinnon, F. Courrios, H.F.L. Meyer-Bahlburg, et al., “Reliability of Sexual Risk Behavior Interviews with Psychiatry Patients,” American Journal of Psychiatry 150 (1993): 972–74.

D. Civic, G. Walsh, and D. Mc-Bride, “Staff Perspectives on Sexual Behavior of Patients in a State Psychiatric Hospital,” Hospital and Community Psychiatry 44 (1993): 887–90.

K. Bhui, A. Puffet, and G. Strathdee, “Sexual and Relationship Problems amongst Patients with Severe Chronic Psychoses,” Social Psychiatry and Psychiatric Epidemiology 32 (1997): 459–67.

M. B. Rosenbaum, “Neuroleptics and Sexual Functioning,” Integrative Psychiatry 4 (1986): 105–6.

G. Sullivan and D. Lukoff, “Sexual Side Effects of Antipsychotic Medication: Evaluation and Interventions,” Hospital and Community Psychiatry 41 (1990): 1238–41.

S. Smith, P. Mostyn, S. Vearnals, et al., “The Prevalence of Sexual Dysfunction in Schizophrenic Patients Taking Conventional Antipsychotic Medication,” Schizophrenia Research 41 (2000): 218.

D. D. Gold and J.D. Justino, “‘Bicycle Kickstand’ Phenomenon: Prolonged Erections Associated with Antipsychotic Drugs,” Southern Medical Journal 81 (1988): 792–94.

M. V. Seeman, M. Lang, and N. Rector, “Chronic Schizophrenia: A Risk Factor for HIV?” Canadian Journal of Psychiatry 35 (1990): 765–68.

J. H. Coverdale and J.A. Aruffo, “Family Planning Needs of Female Chronic Psychiatric Outpatients,” American Journal of Psychiatry 146 (1989): 1489–91.

L. M. Howard, G. Thornicroft, M. Salmon, et al., “Predictors of Parenting Outcome in Women with Psychotic Disorders Discharged from Mother and Baby Units,” Acta Psychiatrica Scandinavica 110 (2004): 347–55.

M. Mullick, L.J. Miller, and T. Jacobsen, “Insight into Mental Illness and Child Maltreatment Risk among Mothers with Major Psychiatric Disorders,” Psychiatric Services 52 (2001): 488–92.

L. B. McCullough, J. Coverdale, T. Bayer, et al., “Ethically Justified Guidelines for Family Planning Interventions to Prevent Pregnancy in Female Patients with Chronic Mental Illness,” American Journal of Obstetrics and Gynecology 167 (1992): 19–25.

B. E. Bennedsen, P.B. Mortensen, A.V. Olesen, et al., “Preterm Birth and Intra-Uterine Growth Retardation among Children of Women with Schizophrenia,” British Journal of Psychiatry 175 (1999): 239–45.

A. Jablensky, S. Zubrick, V. Morgan, et al., “The Offspring of Women with Schizophrenia and Affective Psychoses: A Population Study,” Schizophrenia Research 41 (2000): 8.

A. Buist, T.R. Norman, and L. Dennerstein, “Breastfeeding and the Use of Psychotropic Medication: A Review,” Journal of Affective Disorders 19 (1990): 197–206.

D. Gamino, “1 in 24 New Austin State Hospital Patients Has HIV,” Austin American– Statesman, August 22, 1991.

F. Cournos, M. Empfield, E. Horwath, et al., “HIV Seroprevalence among Patients Admitted to Two Psychiatric Hospitals,” American Journal of Psychiatry 148 (1991): 1225–30.

M. Sacks, H. Dermatis, S. Looser– Ott, et al., “Seroprevalence of HIV and Risk Factors for AIDS in Psychiatric Inpatients,” Hospital and Community Psychiatry 43 (1992): 736–37.

W. D. Klinkenberg, J. Caslyn, G.A. Morse, et al., “Prevalence of Human Immunodeficiency Virus, Hepatitis B, and Hepatitis C among Homeless Persons with Co-occurring Severe Mental Illness and Substance Use Disorders,” Comprehensive Psychiatry 44 (2003): 293–302.

J. F. Aruffo, J.H. Coverdale, R.C. Chacko, et al., “Knowledge about AIDS among Women Psychiatric Outpatients,” Hospital and Community Psychiatry 41 (1990): 326–28.

F. Cournos, K. McKinnon, H. Meyer-Bahlburg, et al., “HIV Risk Activity among Persons with Severe Mental Illness: Preliminary Findings,” Hospital and Community Psychiatry 44 (1993): 1104–6.

R. M. Goisman, A.B. Kent, E.C. Montgomery, et al., “AIDS Education for Patients with Chronic Mental Illness,” Community Mental Health Journal 27 (1991): 189–97.

J. A. Kelly, T.L. McAuliffe, K.J. Sikkema, et al., “Reduction in Risk Behavior among Adults with Severe Mental Illness Who Learned to Advocate for HIV Prevention,” Psychiatric Services 48 (1997): 1283–88.

D. J. Sells, M. Rowe, D. Fisk, et al., “Violent Victimization of Persons with Co– occurring Psychiatric and Substance Use Disorders,” Psychiatric Services 54 (2003): 1253–57.

A. F. Lehman and L.S. Linn, “Crimes against Discharged Mental Patients in Boardand-Care Homes,” American Journal of Psychiatry 141 (1984): 271–74.

V. A. Hiday, M.S. Swartz, J.W. Swanson, et al., “Criminal Victimization of Persons with Severe Mental Illness,” Psychiatric Services 50 (1999): 62–68.

C. W. Dugger, “Big Shelters Hold Terrors for the Mentally Ill,” New York Times, January 12, 1992, pp. 1 and 22.

S. Friedman and G. Harrison, “Sexual Histories, Attitudes, and Behavior of Schizophrenic and ‘Normal’ Women,” Archives of Sexual Behavior 13 (1984): 555–67.

L. A. Goodman, M.A. Dutton, and M. Harris, “Episodically Homeless Women with Serious Mental Illness: Prevalence of Physical and Sexual Assault,” American Journal of Orthopsychiatry 65 (1995): 468–78.

J. M. Darvez-Bornoz, T. Lemperiere, A. Degiovanni, and P. Grillard, “Sexual Victimization in Women with Schizophrenia and Bipolar Disorder,” Social Psychiatry and Psychiatric Epidemiology 30 (1995): 78–84.

C. J. Cooper, “Brutal Lives of Homeless S.F. Women,” San Francisco Examiner, December 18, 1988, p. A-1.

J. A. Marley and S. Buila, “When Violence Happens to People with Mental Illness: Disclosing Victimization,” American Journal of Orthopsychiatry 69 (1999): 398–402.

T. Marshall and P. Solomon, “Professionals’ Responsibilities in Releasing Information to Families of Adults with Mental Illness,” Psychiatric Services 54 (2003): 1622–28.

N. Dearth, B.J. Labenski, M.E. Mott, et al., Families Helping Families (New York: Norton, 1986), p. 61.

T. Bogart and P. Solomon, “Procedures to Share Treatment Information among Mental Health Providers, Consumers, and Families,” Psychiatric Services 50 (1999): 1321–25.

P. J. Weiden, L. Dixon, A. Frances, et al., “Neuroleptic Noncompliance in Schizophrenia,” in C.A. Tamminga and S.C. Schulz, eds., Advances in Neuropsychiatry and Psychopharmacology. Vol. 1: Schizophrenia Research (New York: Raven Press, 1991), pp. 285–96.

P. J. Weiden and M. Olfson, “Measuring Costs of Rehospitalization in Schizophrenia,” presented at the annual meeting of the American Psychiatric Association, San Francisco, California, May 1993.

I. E. Lin, R. Spiga, and W. Fortsch, “Insight and Adherence to Medication in Chronic Schizophrenics,” Journal of Clinical Psychiatry 40 (1979): 430–32.

D. Minor, quoted in A.B. Hatfield and H.P. Lefley, Surviving Mental Illness (New York: Guilford Press, 1993), p. 134.

E. Leete, “The Treatment of Schizophrenia: A Patient’s Perspective,” Hospital and Community Psychiatry 38 (1987): 486–91.

M. Vanelli, P. Burstein, and J. Cramer, “Refill Patterns of Atypical and Conventional Antipsychotic Medications at a National Retail Pharmacy Chain,” Psychiatric Services 52 (2001): 1248–50.

M. Valenstein, F.C. Blow, L.A. Copeland, et al., “Poor Antipsychotic Adherence among Patients with Schizophrenia: Medication and Patient Factors,” Schizophrenia Bulletin 30 (2004): 255–64.

P. J. Weiden, J.J. Mann, G. Haas, et al., “Clinical Nonrecognition of Neuroleptic– Induced Movement Disorders: A Cautionary Study,” American Journal of Psychiatry 144 (1987): 1148–53.

S. E. Finn, J.M. Bailey, R.T. Schultz, et al., “Subjective Utility Ratings of Neuroleptics in Treating Schizophrenia,” Psychological Medicine 20 (1990): 843–48.

T. Van Putten, “Why Do Schizophrenic Patients Refuse to Take Their Drugs?” Archives of General Psychiatry 31 (1974): 67–72.

R. Diamond, “Drugs and the Quality of Life: The Patient’s Point of View,” Journal of Clinical Psychiatry 46 (1985): 29–35.

B. Blaska, “The Myriad Medication Mistakes in Psychiatry: A Consumer’s View,” Hospital and Community Psychiatry 41 (1990): 993–98.

R. McLean, Recovered, Not Cured (Crow’s Nest, Australia: Allen and Unwin, 2003), pp. 160–61.

C. Clary, A. Dever, and E. Schweizer, “Psychiatric Inpatients’ Knowledge of Medication at Hospital Discharge,” Hospital and Community Psychiatry 43 (1992): 140–44.

A. F. Lehman, L.B. Dixon, E. Kernan, et al., “A Randomized Trial of Assertive Community Treatment for Homeless Persons with Severe Mental Illness,” Archives of General Psychiatry 54 (1997): 1038–43.

L. Dixon, P. Weiden, M. Torres, et al., “Assertive Community Treatment and Medication Compliance in the Homeless Mentally Ill,” American Journal of Psychiatry 154 (1997): 1302–4.

D. J. Luchins, P. Hanrahan, K.J. Conrad, et al., “An Agency-Based Representative Payee Program and Improved Community Tenure of Persons with Mental Illness,” Psychiatric Services 49 (1998): 1218–22.

R. Rosenheck, J. Lam, and F. Randolph, “Impact of Representative Payees on Substance Use among Homeless Persons with Serious Mental Illness and Substance Abuse,” Psychiatric Services 48 (1997): 800–806.

M. R. Stoner, “Money Management Services for the Homeless Mentally Ill,” Hospital and Community Psychiatry 40 (1989): 751–53.

P. Gorman, New Hampshire Department of Health and Human Services, personal communication, September 11, 1998.

C. O’Keefe, D.P. Potenza, K.T. Mueser, “Treatment Outcomes for Severely Mentally Ill Patients on Conditional Discharge to Community– Based Treatment,” Journal of Nervous and Mental Disease 185 (1997): 409–11.

J. D. Bloom, M.H. Williams, J.L. Rogers, et al., “Evaluation and Treatment of Insanity Acquittees in the Community,” Bulletin of the American Academy of Psychiatry and Law 14 (1986): 231–44.

J. D. Bloom, M.H. Williams, and D.A. Bigelow, “Monitored Conditional Release of Persons Found Not Guilty by Reason of Insanity,” American Journal of Psychiatry 148 (1991): 444–48.

E. F. Torrey and R.J. Kaplan, “A National Survey of the Use of Outpatient Commitment,” Psychiatric Services 46 (1995): 778–84.

G. Zanni and L. deVeau, “Inpatient Stays before and after Outpatient Commitment,” Hospital and Community Psychiatry 37 (1986): 941–42.

M. R. Munetz, T. Grande, J. Kleist, et al., “The Effectiveness of Outpatient Civil Commitment,” Psychiatric Services 47 (1996): 1251–53.

B. M. Rohland, “The Role of Outpatient Commitment in the Management of Persons with Schizophrenia,” Iowa Consortium for Mental Health, Services, Training, and Research, May 1998.

G. A. Fernandez and S. Nygard, “Impact of Involuntary Outpatient Commitment on the Revolving-Door Syndrome in North Carolina,” Hospital and Community Psychiatry 41 (1990): 1001–4.

M. S. Swartz, J.W. Swanson, H.R. Wagner, et al., “Can Involuntary Outpatient Commitment Reduce Hospital Recidivism?: Findings from a Randomized Trial with Severely Mentally Ill Individuals,” American Journal of Psychiatry 156 (1999): 1968–75.

V. A. Hiday and T.L. Scheid-Cook, “The North Carolina Experience with Outpatient Commitment: A Critical Appraisal,” International Journal of Law and Psychiatry 10 (1987): 215–32.

R. A. Van Putten, J.M. Santiago, and M.R. Berren, “Involuntary Outpatient Commitment in Arizona: A Retrospective Study,” Hospital and Community Psychiatry 39 (1988): 953–58.

J. W. Swanson, M.S. Swartz, R. Borum, et al., “Involuntary Outpatient Commitment and Reduction of Violent Behaviour in Persons with Severe Mental Illness,” British Journal of Psychiatry 176 (2000): 224–31.

J. C. Phelan, M. Sinkewicz, D.M. Castille, et al. “Effectiveness and Outcomes of Assisted Outpatient Treatment in New York State,” Psychiatric Services 61 (2010): 137–43.

Kendra’s Law: An Interim Report on the Status of Assisted Outpatient Treatment (New York State Office of Mental Health, 2003).

H. R. Lamb and L.E. Weinberger, “Conservatorship for Gravely Disabled Psychiatric Patients: A Four-Year Follow-up Study,” American Journal of Psychiatry 149 (1992): 909–13.

J. Geller, A.L. Grud zinskas Jr., M. McDermett, et al., “The Efficacy of Involuntary Outpatient Treatment in Massachusetts,” Administration and Policy in Mental Health 25 (1998): 271–85.

J. L. Geller, “On Being ‘Committed’ to Treatment in the Community,” Innovations and Research 2 (1993): 23–27.

J. L. Geller, “Rights, Wrongs, and the Dilemma of Coerced Community Treatment,” American Journal of Psychiatry 143 (1986): 1259–64.

H. J. Steadman, A. Redlich, L. Callahan, et al., “Effect of Mental Health Courts on Arrests and Jail Days,” Archives of General Psychiatry 68 (2011): 167–72.

V. A. Hiday and B. Ray, “Arrests Two Years after Exiting a Well– Established Mental Health Court,” Psychiatric Services 61 (2010): 463–68.

H. R. Lamb and L.E. Weinberger, “Mental Health Courts as a Way to Provide Treatment to Violent Persons with Severe Mental Illness,” Journal of the American Medical Association 300 (2008): 722–24.

A. F. Lehman, personal communication, October 12, 1998.

S. Kapur, R. Ganguli, R. Ulrich, et al., “Use of Random– Sequence Riboflavin as a Marker of Medication Compliance in Chronic Schizophrenics,” Schizophrenia Research 6 (1992): 49–53.

G. A. Ellard, P.J. Jenner, and P.A. Downs, “An Evaluation of the Potential Use of Isoniazid, Acetylisoniazid and Isonicotinic Acid for Monitoring the Self-Administration of Drugs,” British Journal of Clinical Pharmacology 10 (1980): 369–81.

A. Lucksted and R.D. Coursey, “Consumer Perceptions of Pressure and Force in Psychiatric Treatments,” Psychiatric Services 46 (1995): 146–52.

W. M. Greenberg, L. Moore-Duncan, and R. Herron, “Patients’ Attitudes toward Having Been Forcibly Medicated,” Bulletin of the American Academy of Psychiatry and the Law 24 (1996): 513–24.

R. Reich, “Care of the Chronically Mentally Ill: A National Disgrace,” American Journal of Psychiatry 130 (1997): 912.

A. B. Hatfield, Family Education in Mental Illness (New York: Guilford Press, 1990), p. 124.

D. M. Steinwachs, J.D. Kaspar, and E.A. Skinner, “Family Perspectives on Meeting the Needs for Care of Severely Mentally Ill Relatives: A National Survey” (Arlington, Va.: National Alliance for the Mentally Ill, 1992).

J. Rabkin, “Criminal Behavior of Discharged Mental Patients: A Critical Appraisal of the Research,” Psychological Bulletin 86 (1979): 1–27.

D. A. Martell and P.E. Dietz, “Mentally Disordered Offenders Who Push or Attempt to Push Victims onto Subway Tracks in New York City,” Archives of General Psychiatry 49 (1992): 472–75.

J. Monahan, “Mental Disorder and Violent Behavior,” American Psychologist 47 (1992), 511–21.

B. G. Link, H. Andrews, and F.T. Cullen, “The Violent and Illegal Behavior of Mental Patients Reconsidered,” American Sociological Review 57 (1992) 275–92.

J. W. Swanson, C.E. Holzer, V.K. Ganju, et al., “Violence and Psychiatric Disorder in the Community: Evidence from the Epidemiologic Catchment Area Surveys,” Hospital and Community Psychiatry 41 (1990): 761–70.

J. Monahan, “Mental Disorder and Violent Behavior,” American Psychologist 47 (1992): 511–21.

P. M. Marzuk, “Violence, Crime, and Mental Illness,” Archives of General Psychiatry 53 (1996): 481–86

J. W. Swanson, E.E. McGinty, S. Fazel, et al., “Mental Illness and Reduction of Gun Violence and Suicide: Bringing Epidemiologic Research to Policy,” Annals of Epidemiology 25 (2015): 366– 76.

E. F. Torrey, Out of the Shadows: Confronting America’s Mental Illness Crisis (New York: John Wiley, 1997), chapter 3, pp. 25–42.

B. A. Palmer, V.S. Pankratz, and J.M. Bostwick, “The Lifetime Risk of Suicide in Schizophrenia,” Archives of General Psychiatry 62 (2005): 247–53.

C. P. Miles, “Conditions Predisposing to Suicide: A Review,” Journal of Nervous and Mental Disease 164 (1977): 231–46.

H. Heilä, “Suicide in Schizophrenia – A Review,” Psychiatria Fennica 30 (1999): 59–79.

M. De Hert, K. McKenzie, and J. Peuskens, “Risk Factors for Suicide in Young People Suffering from Schizophrenia: A Long-Term Follow-up Study,” Schizophrenia Research 47 (2001): 127–34.